http://www.pharmalot.com/2008/08/uk-health-chief-perverse-incentives-raise-prices/ News, Comment and Conversation Fri, 10 Feb 2012 21:08:16 +0000 http://wordpress.org/?v=2.6.2 http://www.pharmalot.com/2008/08/uk-health-chief-perverse-incentives-raise-prices/#comment-369529 Supremacy Claus Tue, 19 Aug 2008 01:53:06 +0000 http://www.pharmalot.com/?p=15071#comment-369529 This is Brit twit Commie Care. If the US adopts Commie Care, it will get cheap care. This is Brit twit Commie Care. If the US adopts Commie Care, it will get cheap care.

]]> http://www.pharmalot.com/2008/08/uk-health-chief-perverse-incentives-raise-prices/#comment-369465 David Gerard Mon, 18 Aug 2008 15:05:48 +0000 http://www.pharmalot.com/?p=15071#comment-369465 Of course they can't give away expensive cancer drugs, there's too much demand for free NHS Viagra. My take: http://notnews.today.com/2008/08/18/drug-firms-deny-pricing-for-profit/ Of course they can’t give away expensive cancer drugs, there’s too much demand for free NHS Viagra. My take: http://notnews.today.com/2008/08/18/drug-firms-deny-pricing-for-profit/

]]> http://www.pharmalot.com/2008/08/uk-health-chief-perverse-incentives-raise-prices/#comment-369459 atlex Mon, 18 Aug 2008 12:13:45 +0000 http://www.pharmalot.com/?p=15071#comment-369459 Maybe I'm missing something here. CEOs work for stockholders and their job is to increase shareholder value. In the US people complain that CEO compensation is not closely enough linked to performance; CEOs often get paid millions while shareholder value declines. This bureaucrat now says that linking CEO compensation to shareholder value (ie, stock price) is a bad thing. He seems to imply that "healthy profits" are a bad thing. Let's face it, his job is to minimize healthcare spending; his preference is that no new technologies enter the market. This is a blatant attempt to deflect criticism of NICE's backward position on cancer drugs, Alzheimer's drugs, etc. Maybe I’m missing something here. CEOs work for stockholders and their job is to increase shareholder value. In the US people complain that CEO compensation is not closely enough linked to performance; CEOs often get paid millions while shareholder value declines. This bureaucrat now says that linking CEO compensation to shareholder value (ie, stock price) is a bad thing. He seems to imply that “healthy profits” are a bad thing. Let’s face it, his job is to minimize healthcare spending; his preference is that no new technologies enter the market. This is a blatant attempt to deflect criticism of NICE’s backward position on cancer drugs, Alzheimer’s drugs, etc.

]]>